China, U.S. Strengthen Drug Control Cooperation in 2025
China and the U.S. enhance drug control collaboration in 2025, building on recent bilateral agreements and cross-departmental efforts to address global narcotics challenges.
News & Insights Across Asia
China and the U.S. enhance drug control collaboration in 2025, building on recent bilateral agreements and cross-departmental efforts to address global narcotics challenges.
China calls on the U.S. to take concrete steps for cooperation in addressing the fentanyl crisis, reaffirming its strict anti-drug policies and commitment to global collaboration.
China’s Foreign Ministry accuses U.S. fentanyl tariffs of undermining bilateral anti-drug efforts, urging equal dialogue to resolve disputes.
China warns US tariffs over fentanyl exports are damaging bilateral anti-drug cooperation, urging equal dialogue to address opioid crisis concerns.
China criticizes US for using fentanyl concerns to justify tariffs, announces retaliatory measures amid trade tensions.
China publishes white paper detailing strict fentanyl controls, tech-driven tracking, and international cooperation to combat global drug threats.